Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to ensure that people with mild cognitive impairment or mild dementia are diagnosed early enough to benefit from novel treatments if approved by the National Institute for Health and Care Excellence in the future.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. The NHS in England is legally required to fund medicines recommended in a NICE appraisal, usually within three months of final guidance.

A timely diagnosis is vital to ensuring that a person with dementia can access the advice, information, care, and support that can help them to live well and remain independent for as long as possible. We remain committed to recovering the dementia diagnosis rate to the national ambition of 66.7%. The latest dementia diagnosis rate reported by NHS England for the end of September 2025 was 66.3%.

To support commissioners and providers with appropriate data and to enable targeted support where needed, we have developed a memory service dashboard for management information purposes.

Our health system has struggled to support those with complex needs, including those with dementia. Under the 10-Year Health Plan, those living with dementia will benefit from improved care planning and better services.

We will deliver the first ever Modern Service Framework for Frailty and Dementia to deliver rapid and significant improvements in quality of care and productivity. This will be informed by phase one of the independent commission into adult social care, expected in 2026.